ARTICLE | Clinical News
Tequin gatifloxacin regulatory update
September 15, 2008 7:00 AM UTC
FDA posted a notice of determination that Bristol-Myers' Tequin gatifloxacin had been withdrawn from sale for safety reasons, which means the agency will not accept nor approve any ANDAs referencing t...